BOSTON, Feb. 5, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk ...

CK Life Sciences International is set to merge its subsidiary Polynoma with Nasdaq-listed TransCode Therapeutics, in a move expected to boost the pipeline of anticancer drugs, according to the biotech ...

TransCode acquires 100% of the issued and outstanding interests of Polynoma from CK Life Sciences Concurrent equity investment of $25 Million from CK Life Sciences into TransCode TransCode expands its ...

In a pair of deals, TransCode Therapeutics has bagged Polynoma and its phase 3 cancer vaccine, as well as a $25 million injection into its cash-strapped coffers—but in doing so, the company is trading ...

Investing.com -- TransCode Therapeutics (NASDAQ:RNAZ) stock surged 50% after announcing the acquisition of Polynoma and a $25 million strategic financing from a subsidiary of CK Life Sciences. The ...

BOSTON/SAN DIEGO - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a micro-cap biotech company currently valued at approximately $10 million, announced today it has acquired Polynoma LLC, a privately-held ...

These policies let you invest your cash value directly in mutual fund-like accounts, but they also carry risks if the investments lose money Written By Written by Insurance Staff Writer, WSJ | Buy ...

Variable universal life insurance (VUL) offers flexibility, but it also comes with investment risk. Many, or all, of the products featured on this page are from our advertising partners who compensate ...

Although software transcoding is accept­able for transcoding most VOD streams and even low-volume live programming, most high-volume live applications need hardware for efficient transcoding, both to ...

Microsoft PowerToys is a free application that brings a bunch of advanced features to Windows for power users. Some of those tools give you more control over your mouse and keyboard settings. Others ...

(RTTNews) - TransCode Therapeutics, Inc. (RNAZ), an oncology company focused on RNA therapeutics for cancer treatment, announced on Tuesday that it has regained compliance with Nasdaq's continued ...